ArticleClinical epigenetics2025

Exposing the DNA methylation-responsive compartment of the leukaemic genome in T-ALL cell lines support its potential as a novel therapeutic target in T-ALL.

Maike Bensberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.